Bioniz - Pipeline

BNZ-3

IL-4, IL-9, & IL-21 Inhibitor

BNZ-3 is an early stage asset targeting IL-4, IL-9, & IL-21 cytokines. It has potential for a wide range of prevalent diseases including COPD, Asthma, Sjögren’s syndrome, & Lupus.